mizacorat (AZD9567) / AstraZeneca  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mizacorat (AZD9567) / AstraZeneca
NCT02512575: A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.

Completed
1
72
Europe
AZD9567 Monohydrat, Placebo oral suspension/ Placebo capsule, Prednisolone
AstraZeneca
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Healthy Subjects, Rheumatoid Arthritis
09/16
09/16
NCT02760316: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of AZD9567.

Completed
1
64
Europe
AZD9567 10 mg, AZD9567 20 mg, AZD9567 40 mg, AZD9567 80 mg, Prednisolone 20 mg, AZD9567 125 mg, AZD9567 155 mg, Prednisolone 5 mg, Prednisolone 40 mg
AstraZeneca
Rheumatoid Arthritis
09/17
09/17

Download Options